Submitted March 13, 2006
Accepted April 18, 2006
Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy
Lucia Mazzolai*, Patrick Hohlfeld, Francois Spertini, Daniel Hayoz, Marc Schapira, and Michel A Duchosal
Vascular Medicine, University Hospital of Lausanne (CHUV), Switzerland
Obstetrics, University Hospital of Lausanne (CHUV), Switzerland
Immunology and Allergy, University Hospital of Lausanne (CHUV), Switzerland
Hematology of the University Hospital of Lausanne (CHUV), Switzerland
* Corresponding author; email: lucia.mazzolai{at}chuv.ch.
Heparin is the drug of choice for the treatment or the prevention of thromboembolic disease during pregnancy. However, treatment options are limited when heparin cannot be used because of hypersensitivity skin reactions. Despite the recent availability of new anticoagulant agents, data relating to their use during pregnancy is lacking. This report describes the successful management with fondaparinux, during 150 days, of a pregnant patient with protein S deficiency and prior DVT who developed heparin and danaparoid hypersensitivity.